DE-obligation of funds from FY2016 expiring lines.
Ended Purchase Order Awarded Last action
- Contract number
- HHSN261201600552P
- Awardee
-
Tecan U.s., Inc. UEI EMSJF133EBY9
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,605
Award facts
- Contract value 100% obligated
- $3,604.93 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$0 | |
| Original award | $3,605 |
About this award
The National Cancer Institute issued a purchase order to Tecan U.S., Inc. on August 16, 2016, valued at $3,604.93 for firm fixed price, with an ultimate completion date of May 23, 2021. The order represents a de-obligation of funds from expiring FY2016 lines with no set-aside. Place of performance is Bethesda, Maryland.
Quick answers
Who was awarded contract HHSN261201600552P?
HHSN261201600552P was awarded to Tecan U.s., Inc. by National Cancer Institute (National Institutes of Health) on August 16, 2016.
How much is contract HHSN261201600552P worth?
The government has obligated $3,605 on HHSN261201600552P.
Was contract HHSN261201600552P competed?
The extent of competition for HHSN261201600552P was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award